Scholar Rock (NASDAQ:SRRK) Trading 2.9% Higher

Scholar Rock Holding Co. (NASDAQ:SRRK - Get Free Report)'s share price traded up 2.9% during mid-day trading on Tuesday . The stock traded as high as $13.75 and last traded at $13.72. 49,355 shares traded hands during mid-day trading, a decline of 94% from the average session volume of 776,547 shares. The stock had previously closed at $13.33.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Wedbush reiterated an "outperform" rating and issued a $23.00 price objective on shares of Scholar Rock in a report on Tuesday, January 23rd. Raymond James assumed coverage on shares of Scholar Rock in a report on Thursday, March 28th. They issued a "strong-buy" rating and a $30.00 price objective for the company. Piper Sandler reiterated an "overweight" rating and issued a $28.00 price objective on shares of Scholar Rock in a report on Tuesday, March 26th. Truist Financial restated a "buy" rating and set a $20.00 target price on shares of Scholar Rock in a report on Wednesday, April 3rd. Finally, HC Wainwright restated a "buy" rating and set a $30.00 target price on shares of Scholar Rock in a report on Tuesday, March 19th. Five equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Scholar Rock has an average rating of "Buy" and an average target price of $25.17.

Scholar Rock Stock Up 5.0 %

The stock has a market capitalization of $1.09 billion, a P/E ratio of -7.04 and a beta of 0.90. The company has a debt-to-equity ratio of 0.22, a current ratio of 8.80 and a quick ratio of 8.80. The stock's fifty day moving average is $15.55 and its two-hundred day moving average is $14.20.

Scholar Rock (NASDAQ:SRRK - Get Free Report) last issued its quarterly earnings results on Tuesday, March 19th. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.01). As a group, research analysts predict that Scholar Rock Holding Co. will post -2.01 earnings per share for the current fiscal year.

Insider Activity at Scholar Rock

In related news, CFO Edward H. Myles sold 4,744 shares of the company's stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $15.74, for a total value of $74,670.56. Following the completion of the sale, the chief financial officer now owns 210,976 shares in the company, valued at approximately $3,320,762.24. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Scholar Rock news, insider Mo Qatanani sold 2,512 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $15.74, for a total value of $39,538.88. Following the completion of the sale, the insider now owns 147,019 shares in the company, valued at approximately $2,314,079.06. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Edward H. Myles sold 4,744 shares of the stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $15.74, for a total transaction of $74,670.56. Following the completion of the sale, the chief financial officer now owns 210,976 shares of the company's stock, valued at approximately $3,320,762.24. The disclosure for this sale can be found here. In the last 90 days, insiders sold 22,359 shares of company stock worth $351,931. 26.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Scholar Rock

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD raised its holdings in shares of Scholar Rock by 47.2% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 8,436,185 shares of the company's stock valued at $46,315,000 after purchasing an additional 2,704,442 shares in the last quarter. Polar Capital Holdings Plc bought a new position in shares of Scholar Rock during the 3rd quarter valued at $10,664,000. BlackRock Inc. raised its holdings in shares of Scholar Rock by 115.5% during the 2nd quarter. BlackRock Inc. now owns 2,790,971 shares of the company's stock valued at $21,044,000 after purchasing an additional 1,495,618 shares in the last quarter. Point72 Asset Management L.P. bought a new position in shares of Scholar Rock during the 4th quarter valued at $21,275,000. Finally, Bank of America Corp DE raised its holdings in shares of Scholar Rock by 2,187.0% during the 4th quarter. Bank of America Corp DE now owns 1,050,631 shares of the company's stock valued at $9,508,000 after purchasing an additional 1,004,692 shares in the last quarter. Hedge funds and other institutional investors own 91.08% of the company's stock.

Scholar Rock Company Profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.